Last reviewed · How we verify
NCT05632250: MORGEN
A Prospective, Multi Centre, Interventional, Non-comparator, Open Label Study to Demonstrate the Efficacy, Safety, and Performance of ConvaFoam™ Dressings in the Management of Indicated Chronic Wound Types.
NA trial testing ConvaFoam in Chronic Ulcer of Leg or Foot in 95 participants. Completed in 13 March 2024.
13 March 2024
Quick facts
| Lead sponsor | ConvaTec Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 95 |
| Start date | 10 April 2023 |
| Primary completion | 13 March 2024 |
| Estimated completion | 13 March 2024 |
| Sites | 5 locations across United States |
Drugs / interventions tested
- ConvaFoam
Conditions studied
- Chronic Ulcer of Leg or Foot — all drugs for Chronic Ulcer of Leg or Foot →
- Pressure Injury — all drugs for Pressure Injury →
Sponsor
ConvaTec Inc.
Who can join
18 and older, any sex, with Chronic Ulcer of Leg or Foot or Pressure Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective, multi centre, interventional, non-comparator, open label study to demonstrate the efficacy, safety, and performance of ConvaFoam™ dressings in the management of indicated chronic wound types.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05632250
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of ConvaFoam
Trials testing the same drug.
- NCT05632276 — A Prospective, Multi Centre, Interventional, Non-comparator, Open Label Study to Demonstrate the Efficacy, Performance a · NA · completed
Other ConvaTec Inc. trials
Trials by the same sponsor.
- NCT07342049 — ConvaVAC™ Ag+ Negative Pressure Wound Therapy System in Chronic Wounds · NA · not yet recruiting
- NCT07209358 — EDX110 Randomized Control Trial for Treatment of DFUs · NA · recruiting
- NCT07308678 — AQUACEL® Ag+ Extra™ vs Cutimed® Sorbact® · completed
- NCT06614491 — SCOPE - Single-Point Classification Observational Peristomal Evaluation · completed
- NCT07170566 — A Retrospective, Observational Study of the Real-world Safety and Performance of InnovaMatrix® AC at a Single Centre · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05632250 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by ConvaTec Inc.
- Last refreshed: 30 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05632250.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing